- Home
- SDOT vs NCNA Comparison
SDOT vs NCNA Comparison
Compare SDOT & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SDOT | NCNA |
|---|---|---|
| Founded | 2014 | 1997 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 7.6M |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | SDOT | NCNA |
|---|---|---|
| Price | $2.73 | $3.83 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 48.8K | ★ 65.1K |
| Earning Date | 11-19-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $467,078,000.00 | N/A |
| Revenue This Year | $12.76 | N/A |
| Revenue Next Year | $5.54 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.43 | $2.78 |
| 52 Week High | $41.98 | $330.00 |
Technical Indicators
Market Signals| Indicator | SDOT | NCNA |
|---|---|---|
| Relative Strength Index (RSI) | 31.87 | 43.98 |
| Support Level | $2.76 | $4.10 |
| Resistance Level | $3.54 | $4.55 |
| Average True Range (ATR) | 0.27 | 0.30 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 22.52 | 20.95 |
Price Performance
Historical ComparisonAbout SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.